SS
PHIO icon

SBI Securities’s Phio Pharmaceuticals PHIO Stock Holding History

SBI Securities’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28K Buy
1,247
+23
+2% +$26 ﹤0.01% 2711
2026
Q1 		$1.49K Buy
1,224
+89
+8% +$102 ﹤0.01% 2508
2025
Q4 		$1.19K Buy
1,135
+34
+3% +$54 ﹤0.01% 2579
2025
Q3 		$2.73K Sell
1,101
-808
-42% -$1.84K ﹤0.01% 2305
2025
Q2 		$4.49K Buy
1,909
+941
+97% +$1.9K ﹤0.01% 2034
2025
Q1 		$1.26K Buy
968
+905
+1,437% +$1.67K ﹤0.01% 2487
2024
Q4 		$113 Buy
+63
New +$171 ﹤0.01% 3423

Other funds holding PHIO

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SBI Securities's PHIO Position: Q2 2026 in Review

SBI Securities increased its Phio Pharmaceuticals (PHIO) stake by 1.9% in Q2 2026, buying an estimated $26 and bringing the position to 1,247 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

SBI Securities first reported a position in PHIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.49K in Q2 2025. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

  • SBI Securities held 1,247 shares of Phio Pharmaceuticals worth $1.28K as of Q2 2026.
  • SBI Securities bought 23 Phio Pharmaceuticals shares in Q2 2026, an estimated $26.
  • Phio Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2711 holding.
  • SBI Securities first reported a position in Phio Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Phio Pharmaceuticals position peaked at $4.49K in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.